NHS England
Printable version

Expert team to drive improvements in cancer care

Government announces new National Cancer Board, whose first meeting is today.

  • Expert cancer board to scrutinise progress on faster diagnosis, treatment and care.
  • People with rare cancers, children and young people to have dedicated national voices.
  • First meeting today to drive delivery of the government’s National Cancer Plan.

People with cancer will benefit from stronger national leadership to improve diagnosis, treatment and care, as the reformed National Cancer Board meets for the first time today.

It will scrutinise progress against more than 100 commitments in the National Cancer Plan – including early diagnosis, treatment and quality of life - identifying which areas are falling behind and advising ministers on where further action is needed to ensure every patient receives the best possible care.

The board will have dedicated expert leads for rare cancers, including brain tumours, children and young people with cancer, and inequalities in cancer care.

It builds on the government’s progress to improve cancer care, with all three cancer standards better than a year ago and around 250,000 more people over the last year getting diagnosed on time or having cancer ruled out, compared to the year before the election.

Health and Social Care Secretary Yvette Cooper said:

Most families are affected by cancer at some point in our lives. That is why our National Cancer Plan is so important to provide earlier diagnosis, more advanced treatment and improve outcomes for everyone affected by cancer.

The newly established, independent National Cancer Board will help scrutinise our progress, identify the areas that need most attention, and ensure the voice of cancer patients is constantly heard.

I look forward to working with Anita Charlesworth and her team to deliver the change that every person in our country wants to see, and from which millions of our loved ones will benefit in the years to come.

Independent co-chair Anita Charlesworth will lead the board alongside Mark Cubbon, from NHS England and Department of Health and Social Care, giving patients and the public confidence that progress is being properly scrutinised and held to account.

She will be joined by:

  • Dr Rob Metcalf, clinical lead for rare cancers
  • Dr Dianne Addei, lead for inequalities
  • Ashley Ball-Gamble, lead for children and young people’s cancers. 

The board will meet every quarter and will publish an annual assessment of progress, with a more detailed review after three years to identify where the plan needs to be strengthened or refreshed.

Anita Charlesworth, independent co-chair of the National Cancer Board, said:

Half of us will be diagnosed with cancer during our lives, so this matters profoundly to patients and families right across the country.

The National Cancer Plan is rightly ambitious, and this Board will maintain a relentless focus on earlier diagnosis and making sure innovation reaches every patient, no matter who they are or where they live.

I look forward to working with my fellow members to ensure the National Cancer Board is a force for progress.

Professor Peter Johnson, national clinical director for cancer at NHS England, said:

Our national cancer plan sets out how we will deliver world-class care for cancer patients.

Bringing together clinical experts, charity leaders and patients to scrutinise progress will help ensure we deliver on our commitments, while dedicated leads for rare cancers, children and young people, and inequalities will give a stronger voice to those who can too often be overlooked.

The National Cancer Plan, published in February 2026, set out the government’s ambition for three in four people diagnosed with cancer to be cancer-free or living well five years after diagnosis by 2035.

Alongside improving cancer care performance, the government has also begun rolling out key commitments from the plan, including expanding access to lung cancer screening, expanding Community Diagnostic Centres, improving access to cutting-edge treatments and research, and strengthening support for children and young people, people living with and beyond cancer, and those with rare cancers.

The government has also delivered world-leading action on prevention through the Tobacco and Vapes Act which will create the first smoke-free generation, alongside targeted screening programmes and expanded access to advanced radiotherapy.

Michelle Mitchell, Chief Executive at Cancer Research UK, said:  

Delivering lasting change for people affected by cancer will require strong leadership and clear accountability. It’s encouraging to see dedicated expertise brought together to drive much-needed improvements including detecting cancer earlier, reducing unacceptable waiting times and improving access to the best treatment. 

Beating cancer means beating it for everyone, and delivering on the commitments made by the Government will be essential to improve cancer outcomes and address the challenges faced by people with cancer.

Gemma Peters, Chief Executive at Macmillan Cancer Support, said: 

The first meeting of the National Cancer Board is an important moment for turning the National Cancer Plan from ambition into action. 

The Plan set out bold commitments to improve people’s quality of life and experience of care alongside cancer outcomes. People living with cancer now need to see those commitments translated into real change. We are particularly pleased that a dedicated inequalities lead has been appointed. Embedding commitment to narrowing inequalities from the start is the only way the Plan can truly be delivered. 

Macmillan is ready to work with partners across the system to help turn the Plan’s ambitions into meaningful improvements for everyone living with cancer.

Chris Walden, CEO at Cancer52 said:  

The first meeting of the National Cancer Board marks an important step in bringing together the leadership and expertise needed to drive progress on cancer outcomes in England.  

Cancer52 is proud to bring the collective voice and experience of our member charities to the Board, helping to ensure that the distinct needs of people with rare and less common cancers remain central to its work.  

The National Cancer Plan’s dedicated focus on these cancers is a landmark commitment and we look forward to helping turn that ambition into meaningful and measurable progress for patients.

Rachel Kirby-Rider, Chief Executive at Young Lives vs Cancer said: 

Every day 12 children and young people are diagnosed with cancer, bringing many challenges that impact almost every aspect of their and their families’ lives. 

It’s historic that the National Cancer Plan includes a dedicated chapter for children and young people for the first time. We’re delighted the expert National Cancer Board has launched to lead the progress on the Plan’s commitments - including for children and young people. 

We are pleased to see the appointment of Ashley Ball-Gamble, CEO of CCLG and Chair of the Children and Young People’s Cancer Coalition, as the Board’s lead for children and young people’s cancers. He is an expert, dedicated champion of improving young cancer patients’ experiences and outcomes, and we look forward to continuing to work with him and the government to ensure children, young people and their families get the support they need when facing cancer.

Dr Sara Stoneham, Chair, CCLG: The Children & Young People’s Cancer Association, consultant paediatric and Teenage and Young Adult oncologist said: 

Following the welcome inclusion of a specific children and young people’s chapter and recommendations in the National Cancer Plan, we are pleased that the reformed National Cancer Board will include a dedicated expert lead for children and young people’s cancer. 

This important appointment will support the implementation and delivery of the children and young people’s recommendations in the National Cancer Plan, and scrutinise progress towards achieving the vital progress needed for young cancer patients and their families.  

We look forward to continuing to work with partners in government and the NHS, charities and the wider children and young people’s cancer community to ensure these ambitions become a reality.

 

Channel website: https://www.england.nhs.uk/

Original article link: https://www.gov.uk/government/news/expert-team-to-drive-improvements-in-cancer-care

Share this article

Latest News from
NHS England

NHS rolls out discreet home-testing kits against cervical cancer for millions of women

25/08/2026 13:10:00

Nearly 4 million women will be offered HPV self-testing kits if they have not attended cervical screening appointments following invitations from the NHS in England.

The NHS is starting to roll out the new self-testing kits from today to encourage more women to complete their potentially lifesaving screening to detect human papillomavirus (HPV), which can increase the risk of cervical cancer.

England’s leading women’s health doctor described the move as a “gamechanger” given that around a third of those eligible aren’t up to date with their cervical screening, and this test provides a more “discreet and convenient option” for them.

The self-testing kit contains a swab, similar to a long cotton bud, which is used to collect a sample from the vagina. The sample is then posted back to the NHS for free, where it is checked for high-risk HPV.

If high-risk HPV is found, individuals will be invited to book a follow-up cervical screening appointment at their GP surgery or sexual health clinic, where a nurse or doctor will take a small sample from the cervix to check for cell changes.

Cervical screening helps prevent cervical cancer by checking for high-risk types of HPV. It is a common virus that can cause changes to cells in the cervix. These changes can usually be treated before cancer develops.

Women who are eligible will start receiving invitations today via the NHS App, text message, email or letter, and once invited they will be able to order a free kit through the NHS App or their NHS online account.

This is the next major step the NHS is taking in its pledge to eliminate cervical cancer by 2040, by making it as easy as possible for people to get the lifesaving HPV vaccination and increasing cervical screening attendance.

Dr Sue Mann, National Clinical Director for Women’s Health at NHS England, said: “Screening saves thousands of lives each year by preventing cancers and catching them earlier, but only around two-thirds of women are attending cervical screening appointments when invited by the NHS.

“Offering millions of women an alternative test they can do from the comfort of their own homes will be a gamechanger – making it easier than ever for them to get tested for HPV. 

“There are lots of reasons that may stop women from getting their cervical screening – embarrassment, lack of time, or worries about discomfort – and these kits provide a discreet and convenient option we hope will encourage more women to take up the life-saving test. 

“So, if you’re invited to take part, please order a test – it’s a simple swab you can do at home in minutes.”

Cervical screening appointments with a clinician remain the best way to help prevent cervical cancer, but HPV self-testing is being introduced by the NHS as an additional choice for people who have not taken up previous invitations.

HPV self-testing is an invitation-only offer and is being rolled out in phases across England as part of the NHS Cervical Screening Programme, starting with those aged between 30 and 65, who have not attended cervical screening following previous invitations.

The national rollout comes on the back of the YouScreen trial run by North London cancer alliances in collaboration with NHS England and King’s College London in 2021, which found offering self-testing kits to under-screened women at their GP practice or at home could boost the numbers screened in England by about 400,000 each year.

The UK National Screening Committee used evidence from this trial in its recommendation to roll this out wider.

The latest figures show that 68.8% of eligible women were up to date with their cervical screening – below the NHS England target of 80%. This means around 4 million women in England are not up to date with their routine check-up.

Women aged 24-64 are invited for cervical screening by the NHS every five years, or more frequently if HPV is detected.

Anyone who has been invited for cervical screening can still book an appointment at any time, even if the invitation was sent months or years ago.

It is still important to attend cervical screening appointments if you have been vaccinated against HPV as the vaccine does not provide protection from all types of HPV, so there is a still a small chance of getting cervical cancer.

People who routinely attend for a cervical screening test with a clinician at their GP practice or sexual health clinic should continue to book their appointments as normal.

Health and Social Care Secretary Yvette Cooper said: “Cervical cancer is preventable – but that’s why we want to make it as easy and convenient as possible for women to keep up with their screening.

“These free self-testing kits will be offered to four million women who are currently behind on their screening to make it easier for as many women as possible to keep themselves healthy and safe.

“This is the future NHS we are building – there for all of us when we need it, and acting as early as possible to stop preventable deaths.”

Cancer Research UK’s Chief Executive, Michelle Mitchell, said: “Cervical screening is a powerful tool that saves lives – it can prevent cervical cancer or spot it at an earlier stage when treatment is more likely to be successful. 

“While it’s best for cervical screening to be done by a nurse or doctor, there are barriers that make it challenging for some people to attend. At-home HPV self-testing kits will help more people take part in a way that works for them.

“If people receive their cervical screening or self-testing kit invitation, please consider taking up the offer and encourage loved ones to do the same. Beating cervical cancer means beating it for everyone, and this move brings us closer to that goal.”

Athena Lamnisos, Chief Executive Officer at The Eve Appeal, said: “There are many reasons why those eligible for cervical screening don’t attend.

“Challenges around the type of test it is, limited awareness around HPV and its role in cancer development, as well as practical barriers such as problems around booking and attending an appointment, stop many from going.

“Cervical screening is designed to prevent cervical cancer rather than respond to symptoms, attending a clinic requires people to actively prioritise an appointment among the many competing demands of everyday life.

“Self-testing which can be done at home will be a step-change for many. We have the incredible opportunity to see the back of cervical cancer. How brilliant would that be? But to achieve this, we need to support everyone eligible to attend screening.

“At Eve we welcome the rollout of this programme and its focus on the audiences who need it most in the first stage of the screening pathway. Looking to the future, we hope that self-testing will provide the under-screened and never screened with a new option to help address some of the key barriers. 

“This is not a replacement for clinician screening, and we will continue to work with and support those attending their traditional cervical screening, to help make their appointments more comfortable and accessible. 

“The NHS has set a 2040 target for eliminating cervical cancer. We hope that rolling out self-testing will help us reach it.”

Dawn Bryant, 62, from Hertfordshire, had cancerous cells found early thanks to NHS cervical screening and feels extremely lucky that it was detected and treated before the cancer progressed any further.

She says cervical screening may have saved her life and is encouraging other women who haven’t had theirs yet or have put it off, to book an appointment or do the at-home HPV test if invited.

“My nan died of cervical cancer when I was only 11 so I know how difficult it can be and how important cervical screening is.

“A screening test when I was 32 found I had severe high-grade cell changes, and after further testing I was told it was cancer. 

“I am so lucky it was found at an early stage and could be easily treated. I had some surgery to remove the cells, but I didn’t have to have chemotherapy, radiotherapy, or anything. It was a very scary time, but who knows what would have happened if I’d delayed having the test. 

“Since then, I have been regularly monitored, and had many tests and colposcopies, and although they can be a bit uncomfortable, I would not think twice about having them done again.

“I know lots of women who have put off having screening, and sadly, some who have been diagnosed with advanced cervical cancer after putting it off for years.

“It is so important women go for these check-ups or do the home-testing kit if invited. It doesn’t take very long and if you’re worried or have questions, the staff are excellent and will talk to you and help answer any fears you’ve got.”